ResearcherMashhad University of Medical SciencesActive in the last 2 years
Ghazaleh Pourali
Matched on ORCID iD 0000-0001-8981-0947; OpenAlex author ID A5086792125. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2023: 2 papers · 2024: 2 papers
Papers 4
- The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer. Co-author DOI 10.1007/s11010-023-04790-4↗
- Microbiome as a biomarker and therapeutic target in pancreatic cancer. Co-author DOI 10.1186/s12866-023-03166-4↗
- Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer. Co-author DOI 10.1038/s41598-023-42928-y↗
- Therapeutic Potential of Targeting Transforming Growth Factor-beta (TGF-β) and Programmed Death-ligand 1 (PD-L1) in Pancreatic Cancer. Co-author DOI 10.2174/0113894501264450231129042256↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Majid Khazaei · 4 shared papers, 2023–2024 · strength 0.70
- Paper The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer. DOI 10.1007/s11010-023-04790-4↗
- Paper Microbiome as a biomarker and therapeutic target in pancreatic cancer. DOI 10.1186/s12866-023-03166-4↗
- Paper Therapeutic Potential of Targeting Transforming Growth Factor-beta (TGF-β) and Programmed Death-ligand 1 (PD-L1) in Pan… DOI 10.2174/0113894501264450231129042256↗
- Gordon A. Ferns · 3 shared papers, 2023–2024 · strength 0.50
- Paper Microbiome as a biomarker and therapeutic target in pancreatic cancer. DOI 10.1186/s12866-023-03166-4↗
- Paper Therapeutic Potential of Targeting Transforming Growth Factor-beta (TGF-β) and Programmed Death-ligand 1 (PD-L1) in Pan… DOI 10.2174/0113894501264450231129042256↗
- Paper Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer. DOI 10.1038/s41598-023-42928-y↗
- Amir Avan · 2 shared papers, 2023–2024 · strength 0.37
- Majid Ghayour‐Mobarhan · 2 shared papers, 2023–2024 · strength 0.32
- Amir Avan · 2 shared papers, 2023–2024 · strength 0.32
- Zahra Yousefli · 1 shared paper, 2023 · strength 0.14
- Fatemeh Khojasteh‐Leylakoohi · 1 shared paper, 2023 · strength 0.14
- Alfred King-yin Lam · 1 shared paper, 2023 · strength 0.14
- Elisa Giovannetti · 1 shared paper, 2023 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.